Last reviewed · How we verify

NCT07341711

Long-term Adaptations of Skeletal Muscle After Hybrid Training.

Not yet recruiting NA Last updated 14 January 2026
What this trial tests

NA trial testing Exercise training in Obesity & Overweight in 30 participants. Not yet recruiting.

Timeline
8 January 2026
Primary endpoint
30 June 2026
20 December 2026

Quick facts

Lead sponsorUniversity of Thessaly
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment30
Start date8 January 2026
Primary completion30 June 2026
Estimated completion20 December 2026
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

University of Thessaly

Who can join

Adults 30 to 50, any sex, with Obesity & Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obesity is a major challenge for public health and renders it imperative to reduce its prevalence. High intensity interval training (HIIT) is a form of exercise training that can efficiently induce weight loss in adults with overweight or obesity, even in the absence of dietary intake manipulation. Hybrid type training represents a form of HIIT, that incorporates both cardiorespiratory and musculoskeletal stimuli, by combining multiple types of exercise into a circuit-type, interval style workout. Recent evidence suggests that long-term participation in hybrid HIIT results in significant health-related benefits. However, the molecular mechanisms driving the chronic effects of hybrid HIIT on cardiometabolic and musculoskeletal health remains to be elucidated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise training

Trials testing the same drug.

Other recruiting trials for Obesity & Overweight

Currently open trials in the same condition.

Other University of Thessaly trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07341711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing